Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Sesderma is recalling 45 compacts of Screenses Color Sunscreen due to cGMP deviations. The product is distributed in Florida, Puerto Rico, Colorado, and Georgia.
Sesderma is recalling 66 bottles of Repaskin 50 sunscreen due to cGMP deviations. The product was distributed to Florida, Puerto Rico, Colorado, and Georgia.
Sesderma is recalling 44 compacts of Screenses Color Sunscreen due to cGMP deviations. The product is distributed in Florida, Puerto Rico, Colorado, and Georgia.
Sesderma is recalling 20 bottles of Repaskin 30 sunscreen due to cGMP deviations. The product is distributed in Florida, Puerto Rico, Colorado, and Georgia.
Dr. Reddy's Laboratories is recalling 50,280 bottles of Ondansetron Tablets USP, 4 mg, due to failed impurities and degradation specifications.
Bryant Ranch Prepack Inc. is recalling venlafaxine hydrochloride extended-release tablets that were incorrectly labeled as immediate-release.
VistaPharm is recalling 8,901 cases of Oxycodone Hydrochloride Oral Solution because defective container seals may allow the medication to leak.
Akorn, Inc. is recalling specific batches of PEG-Phen Lubricant Eye Drops because they contain particulate matter. Consumers should stop using the affected products.
A-S Medication Solutions LLC is recalling 2,730 bottles of Acetaminophen & Codeine Phosphate Tablets because the count on the label was incorrect.
Hospira Inc. is recalling 103,600 vials of Quelicin (Succinylcholine Chloride) Injection because the lot number or expiration date may be faded or missing from the primary label.
McKesson Packaging Services is recalling SKY Aspirin Chewable Tablets because the outer cartons were incorrectly labeled. The recall addresses a labeling mix-up.
Impax Laboratories is recalling 67,428 bottles of Dextroamphetamine Sulfate Tablets USP, 10 mg, because the product failed impurities and degradation specifications.
Hospira Inc. is recalling 81,888 bags of Potassium Chloride Injection due to potential contamination with an aromatic hydrocarbon resin.
Hospira Inc. is recalling 4,368 bags of Dextrose Injection, USP, 50% due to potential contamination with an aromatic hydrocarbon resin.
Hospira Inc. is recalling 552 bags of Dextrose Injection, USP, 20% due to potential contamination with an aromatic hydrocarbon resin.
Impax Laboratories is recalling specific lots of Dextroamphetamine Sulfate Tablets because they failed impurity and degradation specifications.
Hospira Inc. is recalling 22,292 bags of Mannitol I.V. 20% due to potential contamination with an aromatic hydrocarbon resin.
Hospira is recalling 11,256 bags of Dextrose Injection, USP, 70% due to potential contamination with an aromatic hydrocarbon resin.
Hospira Inc. is recalling 1,776 bags of Aminosyn-PF (amino acids) 7% due to potential contamination with an aromatic hydrocarbon resin.
AbbVie is recalling 307 bottles of Zemplar (paricalcitol) capsules nationwide because the product failed content uniformity specifications.
Torrent Pharmaceuticals is recalling Telmisartan 80 mg tablets because a product complaint identified silicone foreign matter within the tablets.
Fresenius Kabi is recalling 94,560 vials of Cisatracurium Besylate Injection because the carton labels incorrectly state the product is preservative-free.
Biocon Inc is voluntarily recalling 5,505 bottles of Simvastatin Tablets USP 5 mg because the drug was found to be subpotent. The affected lots were distributed in Pennsylvania, California, and Ohio.
Amerisource Health Services is recalling 228 cartons of Fenofibrate Capsules because some units have incorrect or missing lot and expiration dates.
Impax Laboratories is recalling 28,001 bottles of Fenofibrate Capsules (Micronized) 134 mg because the bottles have incorrect or missing lot and expiration dates.